MediPharm Labs Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	10.58	11.69	17.98	24.15	34.11	19.91
Short-Term Investments	0.7	0.19	0.27	0.76	1.14	2.06
Cash & Short-Term Investments	11.28	11.88	18.25	24.9	35.25	21.97
Cash Growth	-16.00%	-34.92%	-26.73%	-29.36%	60.46%	-44.11%
Accounts Receivable	6.62	6.88	5.52	12.35	15.72	27.72
Other Receivables	1.1	0.63	0.35	0.66	1.2	6.41
Receivables	7.72	7.51	5.87	13.01	16.92	34.14
Inventory	7.93	8.56	9.89	7.78	10.98	22.14
Prepaid Expenses	0.54	0.42	0.64	0.69	1.06	0.44
Other Current Assets	0.46	4.71	2	0.98	1.34	2.84
Total Current Assets	27.93	33.08	36.63	47.35	65.55	81.52
Property, Plant & Equipment	17.95	19.16	25.27	18.11	25.89	34.14
Long-Term Investments	-	-	-	-	-	0.19
Other Intangible Assets	0.72	0.85	1.03	0.04	0.04	0.23
Other Long-Term Assets	-	0.64	1	-	0.88	2.15
Total Assets	46.6	53.73	63.94	65.5	92.36	118.23
Accounts Payable	4.74	4.24	2.13	3.54	2.99	5.55
Accrued Expenses	2.29	4.49	4.91	3.67	4.14	9.25
Short-Term Debt	0.35	0.26	2.11	0.52	-	-
Current Portion of Long-Term Debt	-	-	-	-	-	7.38
Current Portion of Leases	0.07	0.08	0.12	0.08	0.11	0.32
Current Unearned Revenue	0.53	0.61	0.39	0.49	1.32	1
Other Current Liabilities	0.76	0.83	1.21	1.15	0.31	0.75
Total Current Liabilities	8.74	10.5	10.86	9.46	8.88	24.25
Long-Term Debt	-	-	-	-	-	10.54
Long-Term Leases	-	0.05	0.07	0.03	0.1	0.22
Long-Term Unearned Revenue	-	-	-	-	0.23	-
Other Long-Term Liabilities	-	-	-	-	0	4.81
Total Liabilities	8.74	10.55	10.93	9.49	9.22	39.82
Common Stock	201.64	201.21	200.24	191.26	190.55	138.51
Retained Earnings	-188.63	-187.43	-176.73	-163.65	-129.34	-74.54
Comprehensive Income & Other	24.85	29.4	29.49	28.4	21.94	14.45
Total Common Equity	37.86	43.18	53.01	56.01	83.15	78.41
Shareholders' Equity	37.86	43.18	53.01	56.01	83.15	78.41
Total Liabilities & Equity	46.6	53.73	63.94	65.5	92.36	118.23
Total Debt	0.42	0.39	2.3	0.63	0.22	18.46
Net Cash (Debt)	10.86	11.49	15.95	24.27	35.04	3.51
Net Cash Growth	-15.01%	-27.99%	-34.27%	-30.73%	897.86%	-87.78%
Net Cash Per Share	0.03	0.03	0.04	0.09	0.14	0.03
Filing Date Shares Outstanding	420.76	415.14	404.05	282.16	273.94	257.95
Total Common Shares Outstanding	420.76	415.05	401.4	282.16	273.54	155.55
Working Capital	19.19	22.59	25.77	37.89	56.67	57.28
Book Value Per Share	0.09	0.10	0.13	0.20	0.30	0.50
Tangible Book Value	37.14	42.33	51.97	55.97	83.1	78.19
Tangible Book Value Per Share	0.09	0.10	0.13	0.20	0.30	0.50
Land	1.86	1.86	2.81	1.52	1.86	1.89
Buildings	24.97	24.97	27.84	20.93	24.79	25.49
Machinery	14.59	15.1	18.24	17.46	18.88	18.44
Construction In Progress	0.01	0.05	2.5	2.6	4.49	3.26
Leasehold Improvements	0.21	0.21	0.21	0.21	0.21	0.21

Source: S&P Global Market Intelligence. Standard template. Financial Sources.